SCHEMBL1434203

SCHEMBL1434203

CCc1cc[n+]([O-])cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6181011 0.81 CA2 (0.43) —
SCHEMBL6622409 0.78 CA2 (0.47) —
SCHEMBL14370093 0.76 HRH3 (0.50) —
SCHEMBL4071544 0.76 CYP3A4 (0.50) —
SCHEMBL3674028 0.74 — —
SCHEMBL2932220 0.74 — —
SCHEMBL10839040 0.74 GPR84 (0.47) —
SCHEMBL3672063 0.74 — —
SCHEMBL904427 0.74 — —
SCHEMBL904600 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232209-B2 Processes for forming electronic devices including polishing metal-containing layers SPANSION LLC (US) 2012-07-31 — — US claimed
US-8148537-B2 Substituted acetophenones useful as PDE4 inhibitors LEO PHARMA A/S (DK) 2012-04-03 — — US claimed
US-20110136268-A1 PROCESSES FOR FORMING ELECTRONIC DEVICES INCLUDING POLISHING METAL-CONTAINING LAYERS SPANSION LLC (US) 2011-06-09 — — US claimed
EP-2125736-B1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS LEO PHARMA AS (DK) 2011-03-30 — — EP claimed
US-7915169-B2 Processes for forming electronic devices including polishing metal-containing layers SPANSION LLC (US) 2011-03-29 — — US claimed
US-20100035908-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS LEO PHARMA (DK) 2010-02-11 — — US claimed
US-20090117734-A1 PROCESSES FOR FORMING ELECTRONIC DEVICES INCLUDING POLISHING METAL-CONTAINING LAYERS SPANSION LLC (US) 2009-05-07 — — US claimed
US-20240018131-A1 MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF FORESEE PHARMACEUTICALS USA, INC. 2024-01-18 — — US disclosed
US-11739080-B2 Matrix metalloproteinase (MMP) inhibitors and methods of use thereof FORESEE PHARMACEUTICALS USA, INC. (US) 2023-08-29 — — US disclosed
EP-2970224-B1 TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS ONYX THERAPEUTICS INC (US) 2017-09-06 — — EP disclosed
WO-2014152134-A1 TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS ONYX THERAPEUTICS, INC. (US) 2014-09-25 — — WO disclosed
EP-2763966-A1 INSECTICIDAL 2-METHOXYBENZAMIDE DERIVATIVES Syngenta Participations AG (CH) 2014-08-13 — — EP disclosed
US-8497380-B2 Substituted acetophenones useful as PDE4 inhibitors LEO PHARMA A/S (DK) 2013-07-30 — — US disclosed
US-6043248-A VIRICIDES FOR TREATING AN INDIVIDUAL INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS PHARMACIA & UPJOHN COMPANY (US) 2000-03-28 — — US disclosed
US-5837321-A VAPOR DEPOSITION USING YTTRIUM DIKETONATE/PYRIDINE N-OXIDE ADDUCT THE ASSOCIATED OCTEL COMPANY LIMITED (GB) 1998-11-17 — — US disclosed
CN-1183773-A Alpha-substituted pyrimidine-thioalkyl and alkylether compounds UPJOHN CO (US) 1998-06-03 — — CN disclosed
EP-0824524-A1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE PHARMACIA &amp; UPJOHN COMPANY (US) 1998-02-25 — — EP disclosed
WO-1996035678-A1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE PHARMACIA & UPJOHN COMPANY (US) 1996-11-14 — — WO disclosed
WO-1995014698-A1 VOLATILE ORGANIC LANTHANIDE COMPOUNDS AND METHODS FOR THE PREPARATION OF LANTHANIDE-CONTAINING LAYERED MATERIALS FROM THESE COMPOUNDS THE ASSOCIATED OCTEL COMPANY LIMITED (GB) 1995-06-01 — — WO disclosed
US-4066459-A IMINE COMPOUNDS HORIZONS INCORPORATED, A DIVISION OF HORIZONS RESEARCH INCORPORATED (US) 1978-01-03 — — US disclosed
Send feedback